Targeted delivery of doxorubicin for the treatment of bone metastasis from breast cancer using alendronate-functionalized graphene oxide nanosheets

  • Tung Thanh Pham
  • , Hanh Thuy Nguyen
  • , Cao Dai Phung
  • , Shiva Pathak
  • , Shobha Regmi
  • , Dong Ho Ha
  • , Jong Oh Kim
  • , Chul Soon Yong
  • , Sang Kyoon Kim
  • , Ji Eun Choi
  • , Simmyung Yook
  • , Jun Beom Park
  • , Jee Heon Jeong

Research output: Contribution to journalArticlepeer-review

Abstract

Selective delivery of anti-cancer drugs to bone tumors remains an on-going developmental issue due to problems of drug availability and the physiological nature of bone. This study was undertaken to enhance accumulation of doxorubicin (DOX) in bone metastasis microenvironments using alendronate-functionalized graphene oxide nanosheets (NGO-ALs). In vivo biodistribution study showed NGO-ALs were retained for longer and at higher concentrations in bone tumor areas than non-functionalized NGOs. Our findings suggest that NGO-ALs could be used as a promising carrier to enhance antitumor effects and diminish the off-target effects of DOX for the treatment of bone metastasis.

Original languageEnglish
Pages (from-to)310-317
Number of pages8
JournalJournal of Industrial and Engineering Chemistry
Volume76
DOIs
StatePublished - 25 Aug 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alendronate
  • Bone metastasis
  • Graphene oxides
  • Targeted delivery

Fingerprint

Dive into the research topics of 'Targeted delivery of doxorubicin for the treatment of bone metastasis from breast cancer using alendronate-functionalized graphene oxide nanosheets'. Together they form a unique fingerprint.

Cite this